Schedule 13G ownership disclosure

ARIAD PHARMACEUTICALS INC

Security class unavailable · CUSIP: 04033A100

Event date: 2014-07-23

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
9,366,000
Percent of class
5.0100%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-14-003304
Form type
SC 13G
Filer
ADAGE CAPITAL PARTNERS GP, L.L.C.
CIK
CIK 1165408
Filed
Aug 01, 2014
Reporting period
Jul 23, 2014
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub